Literature DB >> 27828894

Rotationally asymmetric multifocal intraocular lenses: preoperative considerations and postoperative outcomes.

Jonathan E Moore1, Richard N McNeely, Eric E Pazo, Tara C B Moore.   

Abstract

PURPOSE OF REVIEW: The manuscript presents a review of recently published studies reporting objective and subjective outcomes and preoperative considerations of asymmetrical multifocal intraocular lenses (IOLs). RECENT
FINDINGS: Current publications suggest that asymmetrical multifocal IOLs provide good, distance, intermediate and near vision for cataract and clear lens extraction patients. The contrast sensitivity achieved is similar to monofocal IOLs. Photopic phenomenon such as glare and halos has been reduced through the use of these IOLs leading to better patient satisfaction. Centration plays a critical role and the lack of a gold standard assessment tool has led to a minority of patients experiencing lower quality of vision and side-effects such as glare and hazy vision. The frequency of dissatisfied patients can be minimized by appropriate patient selection. This is achieved by assessing pupil parameters which guides the surgeon to align the IOL accordingly.
SUMMARY: Asymmetric multifocal IOLs provide the surgeon with an IOL that achieves excellent visual and refractive outcomes enabling patients to see clearly at a range of distances. Subjectively patients report low levels of photopic phenomena and high levels of spectacle independence resulting in high overall patient satisfaction.

Entities:  

Mesh:

Year:  2017        PMID: 27828894     DOI: 10.1097/ICU.0000000000000339

Source DB:  PubMed          Journal:  Curr Opin Ophthalmol        ISSN: 1040-8738            Impact factor:   3.761


  8 in total

1.  Model of the light sword intraocular lens: in-vitro comparative studies.

Authors:  Krzysztof Petelczyc; Andrzej Kolodziejczyk; Narcyz Błocki; Anna Byszewska; Zbigniew Jaroszewicz; Karol Kakarenko; Katarzyna Kołacz; Michał Miler; Alejandro Mira-Agudelo; Walter Torres-Sepúlveda; Marek Rękas
Journal:  Biomed Opt Express       Date:  2019-12-04       Impact factor: 3.732

2.  Comparative analysis of visual quality between unilateral implantation of a trifocal intraocular lens and a rotationally asymmetric refractive multifocal intraocular lens.

Authors:  Na Hui; Mei-Fang Chu; Yan Li; Cong-Yi Wang; Lei Yu; Bo Ma
Journal:  Int J Ophthalmol       Date:  2022-09-18       Impact factor: 1.645

3.  Secondary positioning of rotationally asymmetric refractive multifocal intraocular lens in a patient with glaucoma: A case report.

Authors:  Cong Fan; Yi Zhou; Jian Jiang
Journal:  World J Clin Cases       Date:  2022-07-16       Impact factor: 1.534

4.  Comparison of the visual performance between Oculentis MF30 and Tecnis ZMB00 multifocal intraocular lenses.

Authors:  Lingying Ye; Tianyu Chen; Zhixiang Hu; Qingwen Yang; Qiudong Su; Jin Li
Journal:  Ann Transl Med       Date:  2021-01

5.  Outcomes of a Refractive Segmented Bifocal Intraocular Lens with a Lower Near Addition.

Authors:  Jan A Venter; Barrie M Collins; Stephen J Hannan; David Teenan; Julie M Schallhorn
Journal:  Clin Ophthalmol       Date:  2022-08-10

Review 6.  Comparison of the Clinical Performance of Refractive Rotationally Asymmetric Multifocal IOLs with Other Types of IOLs: A Meta-Analysis.

Authors:  Zequan Xu; Wenzhe Li; Lianqun Wu; Shuang Xue; Xu Chen; Qiang Wu
Journal:  J Ophthalmol       Date:  2018-09-27       Impact factor: 1.909

7.  Comparative Analysis of Visual Performance and Optical Quality with a Rotationally Asymmetric Multifocal Intraocular Lens and an Apodized Diffractive Multifocal Intraocular Lens.

Authors:  Xiao Wang; Haixia Tu; Yong Wang
Journal:  J Ophthalmol       Date:  2020-04-20       Impact factor: 1.909

8.  Comparing prediction accuracy between total keratometry and conventional keratometry in cataract surgery with refractive multifocal intraocular lens implantation.

Authors:  Ho Seok Chung; Jae Lim Chung; Young Jun Kim; Hun Lee; Jae Yong Kim; Hungwon Tchah
Journal:  Sci Rep       Date:  2021-09-28       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.